Mitsubishi UFJ Asset Management Co., Ltd.
Position in RPRX — Royalty Pharma plc
CIK 1466546
TOKYO, M0
Position in RPRX
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$21,240,060
+$5,278,842 QoQ
Shares Held
442,778
+7.2% QoQ
Ownership
0.077%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Mitsubishi UFJ Asset Management Co., Ltd. holds $667,031,036 across 65 Biotechnology names. RPRX ranks #7 (3.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
597,497 | $266,806,310 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
240,600 | $185,897,184 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
152,197 | $50,357,421 | |
| 4 | INSM |
INSMED Inc
|
255,247 | $41,737,989 | |
| 5 | INCY |
Incyte Corp
|
366,912 | $34,533,757 | |
| 6 | MRNA |
Moderna, Inc.
|
424,625 | $21,570,950 | |
| 7 | RPRX |
Royalty Pharma plc
This page
|
442,778 | $21,240,060 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
164,988 | $16,045,083 |
All Filings in RPRX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $21,240,060 | 442,778 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $15,961,218 | 413,075 | Shares | Defined | 2026-02-03 | |
| 2025-09-30 | $12,596,088 | 357,032 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $11,268,130 | 312,743 | Shares | Defined | 2025-08-07 | |
| 2025-03-31 | $9,699,765 | 311,589 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $6,535,381 | 256,189 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $7,223,964 | 255,354 | Shares | Defined | 2024-11-08 | |
| 2024-06-30 | $5,707,390 | 216,435 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $6,573,130 | 216,435 | Shares | Defined | 2024-05-09 | |
| 2023-12-31 | $5,246,172 | 186,763 | Shares | Defined | 2024-02-08 | |
| 2023-09-30 | $5,035,555 | 185,540 | Shares | Defined | 2023-11-07 | |
| 2023-06-30 | $4,993,098 | 162,430 | Shares | Defined | 2023-08-09 | |
| 2023-03-31 | $4,298,811 | 119,312 | Shares | Defined | 2023-05-08 | |
| 2022-12-31 | $4,235,911 | 107,184 | Shares | Defined | 2023-02-07 | |
| 2022-09-30 | $3,953,069 | 98,384 | Shares | Defined | 2022-11-01 | |
| 2022-06-30 | $3,795,539 | 90,284 | Shares | Defined | 2022-08-04 | |
| 2022-03-31 | $3,178,512 | 81,584 | Shares | Defined | 2022-05-09 | |
| 2021-12-31 | $3,308,984 | 83,036 | Shares | Defined | 2022-02-07 | |
| 2021-09-30 | $1,598,689 | 44,236 | Shares | Defined | 2021-11-04 | |
| 2021-06-30 | $1,489,412 | 36,336 | Shares | Defined | 2021-08-06 | |
| 2021-03-31 | $1,597,059 | 36,613 | Shares | Defined | 2021-05-06 | |
| 2020-12-31 | $1,084,283 | 21,664 | Shares | Defined | 2021-02-09 | |
| No filing history on record for this holder in this stock. | ||||||